Location: Stamford
Synced from ClinicalTrials.gov · August 08, 2026
Clinical studies recruiting near Stamford
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine Phase 3 · Ki Health Partners LLC DBA New England Institute for Clinica · H. Lundbeck A/S · NCT05897320 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine Phase 3 · New England Institute Neurology and Headache, Merz Investiga · Merz Therapeutics GmbH · NCT07018700 Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living Phase 3 · Kailera Clinical Site · Kailera · NCT07284979 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease Phase 2/Phase 3 · Smilow Cancer Hospital Care Center at Long Ridge · NRG Oncology · NCT05174169 A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) Phase 3 · Stamford Therapeutics Consortium · Eli Lilly and Company · NCT06672549 A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Out Phase N/A · Stamford Hospital · Novartis Pharmaceuticals · NCT07091019 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol Phase 3 · Smilow Cancer Hospital Care Center at Long Ridge · Alliance for Clinical Trials in Oncology · NCT06876714 Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M Phase 2 · Smilow Cancer Hospital Care Center at Long Ridge · SWOG Cancer Research Network · NCT05806515 E-Mindfulness Approaches for Living After Breast Cancer Phase 3 · Stamford Hospital/Bennett Cancer Center · NRG Oncology · NCT06748222 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine Phase 3 · New England Institute Neurology and Headache, Merz Investiga · Merz Therapeutics GmbH · NCT07018713 A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participant Phase 2 · Stamford Therapeutics Consortium · Eli Lilly and Company · NCT07589608 STOP AF First Post-Approval Study Phase N/A · Cardiology Associates of Fairfield County · Medtronic Cardiac Ablation Solutions · NCT05227053 Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial Phase 2 · Stamford Hospital/Bennett Cancer Center · Alliance for Clinical Trials in Oncology · NCT06632977 A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine Phase 3 · Ki Health Partners LLC DBA New England Institute for Clinica · H. Lundbeck A/S · NCT04965675 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci Phase 3 · Smilow Cancer Hospital Care Center at Long Ridge · National Cancer Institute (NCI) · NCT05256225 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate Phase 3 · Local Institution - 1013 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old Phase 4 · Upsher-Smith Clinical Trial Site #1 · Upsher-Smith Laboratories · NCT04748601 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq Phase 3 · Smilow Cancer Hospital Care Center at Long Ridge · NRG Oncology · NCT04852887 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee Phase 3 · Anthos Investigative Site 1012 · Anthos Therapeutics, Inc. · NCT05712200 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance Phase 3 · Research Site · AstraZeneca · NCT06627647 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, Phase 3 · Smilow Cancer Hospital Care Center at Long Ridge · National Cancer Institute (NCI) · NCT06058377 A Study of Buntanetap in Participants With PD Phase 2/Phase 3 · New England Institute for Clinical Research (Ki Health Partn · Annovis Bio Inc. · NCT07284784 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo Phase 2/Phase 3 · Smilow Cancer Hospital Care Center at Long Ridge · National Cancer Institute (NCI) · NCT05987241 A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Tr Phase 3 · Stamford Hospital ( Site 0049) · Merck Sharp & Dohme LLC · NCT06312176 A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT Phase 3 · Local Institution - 1013 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05511363 Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagn Phase 3 · Smilow Cancer Hospital Care Center at Long Ridge · SWOG Cancer Research Network · NCT06022939 A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab Phase 3 · Smilow Cancer Hospital Care Center at Long Ridge · National Cancer Institute (NCI) · NCT05675410 Clinical Utility of an Amniotic Membrane Allograft for Diabetic Foot Ulcer Wound Management NA · Legacy Medical Consultants · NCT06420245 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Phase 2/Phase 3 · Smilow Cancer Hospital Care Center at Long Ridge · SWOG Cancer Research Network · NCT06616584 S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Phase 3 · Stamford Hospital/Bennett Cancer Center · SWOG Cancer Research Network · NCT03418961
Look up another city
Look up another condition